MedTrace Logo

Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment

NCT07034469 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-12-24

No results posted yet for this study

Summary

TITLE: RCT of air tamponade versus fluorinated gas tamponade for rhegmatogenous retinal detachment DESIGN: Non-inferiority RCT of 150 patients from 10 UK centres AIMS: To assess whether air tamponade is non inferior to gas tamponade for the repair of RRD treated with vitrectomy.

PRIMARY OUTCOME MEASURE: Primary anatomical success with single operation at 24 weeks.

Conditions

  • Retinal Detachment Rhegmatogenous

Interventions

PROCEDURE

air

use of sterile air as a tamponade

PROCEDURE

Gas SF6 (Sulfur Hexafluoride) and others

use of fluorinated gases such as SF6, C2F6 or C3F8 as a tamponade agent

Sponsors & Collaborators

  • Liverpool University Hospitals NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Rumana N Hussain, MBBS, FRCOph · Liverpool University Hospitals NHS Foundation Trust UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-20
Primary Completion
2029-03-20
Completion
2029-03-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07034469 on ClinicalTrials.gov